Federal Register / Vol. 62, No. 214 / Wednesday, November 5, 1997 / Notices 59871

set forth in paragraph 7 of the Act (12

U.S.C. 1817(j)(7)).

The notices are available for

immediate inspection at the Federal

Reserve Bank indicated. The notices

also will be available for inspection at

the offices of the Board of Governors.

Interested persons may express their

views in writing to the Reserve Bank

indicated for that notice or to the offices

of the Board of Governors. Comments

must be received not later than

November 20, 1997.

A. Federal Reserve Bank of

Minneapolis (Karen L. Grandstrand,

Vice President) 250 Marquette Avenue,

Minneapolis, Minnesota 55480-2171:

1. Michael Buckner Owens, Onida,

South Dakota; to acquire additional

voting shares of The Adino Company,

Onida, South Dakota, and thereby

indirectly acquire The Onida Bank,

Onida, South Dakota.

Board of Governors of the Federal Reserve

System, October 31, 1997.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 97–29286 Filed 11–4–97; 8:45 am]

BILLING CODE 6210–01–F

FEDERAL RESERVE SYSTEM

Formations of, Acquisitions by, and

Mergers of Bank Holding Companies

The companies listed in this notice

have applied to the Board for approval,

pursuant to the Bank Holding Company

Act of 1956 (12 U.S.C. 1841 et seq.)

(BHC Act), Regulation Y (12 CFR Part

225), and all other applicable statutes

and regulations to become a bank

holding company and/or to acquire the

assets or the ownership of, control of, or

the power to vote shares of a bank or

bank holding company and all of the

banks and nonbanking companies

owned by the bank holding company,

including the companies listed below.

The applications listed below, as well

as other related filings required by the

Board, are available for immediate

inspection at the Federal Reserve Bank

indicated. The application also will be

available for inspection at the offices of

the Board of Governors. Interested

persons may express their views in

writing on the standards enumerated in

the BHC Act (12 U.S.C. 1842(c)). If the

proposal also involves the acquisition of

a nonbanking company, the review also

includes whether the acquisition of the

nonbanking company complies with the

standards in section 4 of the BHC Act.

Unless otherwise noted, nonbanking

activities will be conducted throughout

the United States.

Unless otherwise noted, comments

regarding each of these applications

must be received at the Reserve Bank

indicated or the offices of the Board of

Governors not later than December 1,

1997.

A. Federal Reserve Bank of

Richmond (A. Linwood Gill III,

Assistant Vice President) 701 East Byrd

Street, Richmond, Virginia 23261-4528:

1. Commercial BancShares,

Incorporated, Parkersburg, West

Virginia; to merge with Gateway

Bancshares, Inc., McMechen, West

Virginia, and thereby indirectly acquire

The Bank of McMechen, McMechen,

West Virginia.

B. Federal Reserve Bank of St. Louis

(Randall C. Sumner, Vice President) 411

Locust Street, St. Louis, Missouri 63102-

2034:

1. Independent Southern Bancshares,

Inc. Employee Stock Ownership Trust,

Brownsville, Tennessee; to acquire up to

35 percent of the voting shares of

Independent Southern Bancshares, Inc.,

Brownsville, Tennessee, and thereby

indirectly acquire Brownsville Bank,

Brownsville, Tennessee, Bank of

Commerce, Trenton, Tennessee,

Tennessee Bank and Trust, Memphis,

Tennessee, and Union Savings Bank,

Covington, Tennessee.

C. Federal Reserve Bank of Dallas

(Genie D. Short, Vice President) 2200

North Pearl Street, Dallas, Texas 75201-

2272:

1. Woodforest Bancshares, Inc.,

Houston, Texas, and Sun Belt

Bancshares, Corporation, Wilmington,

Delaware; to acquire 35 percent of the

voting shares of Main Street National

Bank, Cleveland, Texas.

Board of Governors of the Federal Reserve

System, October 31, 1997.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 97–29285 Filed 11–4–97; 8:45 am]

BILLING CODE 6210–01–F

FEDERAL RESERVE SYSTEM

Sunshine Act Meeting

AGENCY HOLDING THE MEETING: Board of

Governors of the Federal Reserve

System.

TIME AND DATE: 12:00 noon, Monday,

November 10, 1997.

PLACE: Marriner S. Eccles Federal

Reserve Board Building, 20th and C

Streets, N.W., Washington, D.C. 20551.

STATUS: Closed.

MATTERS TO BE CONSIDERED:

1. Personnel actions (appointments,

promotions, assignments,

reassignments, and salary actions)

involving individual Federal Reserve

System employees.

2. Any matters carried forward from a

previously announced meeting.

CONTACT PERSON FOR MORE INFORMATION:

Joseph R. Coyne, Assistant to the Board;

202–452–3204.

SUPPLEMENTARY INFORMATION: You may

call 202–452–3206 beginning at

approximately 5 p.m. two business days

before the meeting for a recorded

announcement of bank and bank

holding company applications

scheduled for the meeting; or you may

contact the Board’s Web site at http://

www.bog.frb.fed.us for an electronic

announcement that not only lists

applications, but also indicates

procedural and other information about

the meeting.

Dated: October 31, 1997.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 97–29316 Filed 10–31–97; 4:34 pm]

BILLING CODE 6210–01–P

FEDERAL TRADE COMMISSION

[File No. 962–3218]

Venegas Inc.; Angel Venegas; Analysis

to Aid Public Comment

AGENCY: Federal Trade Commission.

ACTION: Proposed consent agreement.

SUMMARY: The consent agreement in this

matter settles alleged violations of

federal law prohibiting unfair or

deceptive acts or practices or unfair

methods of competition. The attached

Analysis to Aid Public Comment

describes both the allegations in the

draft complaint that accompanies the

consent agreement and the terms of the

consent order—embodied in the consent

agreement—that would settle these

allegations.

DATES: Comments must be received on

or before January 5, 1998.

ADDRESSES: Comments should be

directed to: FTC/Office of the Secretary,

Room 159, 6th St. and Pa. Ave., N.W.,

Washington, D.C. 20580.

FOR FURTHER INFORMATION CONTACT:

Michael J. Bloom, Federal Trade

Commission, New York Regional

Office, 150 William Street, Suite 1300,

New York, NY 10038. (212) 264–1207.

Donald. G. D’Amato, Federal Trade

Commission, New York Regional

Office, 150 William Street, Suite 1300,

New York, NY 10038. (212) 264–1207.

Denise Tighe, Federal Trade

Commission, New York Regional
59872 Federal Register / Vol. 62, No. 214 / Wednesday, November 5, 1997 / Notices

Office, 150 William Street, Suite 1300,

New York, NY 10038. (212) 264–1207.

SUPPLEMENTARY INFORMATION: Pursuant

to Section 6(f) of the Federal Trade

Commission Act, 38 Stat. 721, 15 U.S.C.

46, and § 2.34 of the Commission’s

Rules of Practice (16 CFR 2.34), notice

is hereby given that the above-captioned

consent agreement containing a consent

order to cease and desist, having been

filed with and accepted, subject to final

approval, by the Commission, has been

placed on the public record for a period

of sixty (60) days. The following

Analysis to Aid Public Comment

describes the terms of the consent

agreement, and the allegations in the

accompanying complaint. An electronic

copy of the full text of the consent

agreement package can be obtained from

the Commission Actions section of the

FTC Home Page (for October 29, 1997),

on the World Wide Web, at ‘‘http://

www.ftc.gov/os/actions97.htm.’’ A

paper copy can be obtained from the

FTC Public Reference Room, Room H–

130, Sixth Street and Pennsylvania

Avenue, N.W., Washington, D.C. 20580,

either in person or by calling (202) 326–

3627. Public comment is invited. Such

comments or views will be considered

by the Commission and will be available

for inspection and copying at its

principal office in accordance with

Section 4.9(b)(6)(ii) of the Commission’s

Rules of Practice (16 CFR 4.9(b)(6)(ii)).

Analysis of Proposed Consent Order To

Aid Public Comment

The Federal Trade Commission has

accepted, subject to final approval, an

agreement to a proposed consent order

from Venegas Inc. (‘‘Venegas’’) and

Angel Venegas.

The proposed consent order has been

placed on the public record for sixty

(60) days for receipt of comments by

interested persons. Comments received

during this period will become part of

the public record. After sixty (60) days,

the Commission will again review the

agreement and comments received and

will decide whether it should withdraw

from the agreement or make final the

agreement’s proposed order.

This matter concerns print

advertisements for proposed

respondents’ Alen, a powdered

nutritional supplement that contains

wheat germ, wheat bran, soybean

extract, and seaweed extract. The

Commission’s complaint alleges that the

proposed respondents made

unsubstantiated representations that

Alen: increases life expectancy; delays

the aging process; eliminates anemia;

increases the immune system’s

defenses; increases memory or

scholastic performance; helps diabetics

naturally produce insulin; reduces the

pain of rheumatism or migraines; lowers

blood pressure; helps heal ulcers;

increases muscle bulk; controls

addictions to excess fat and sweets; and

protects against infections and increases

and enhances the healing process.

The proposed order contains

provisions designed to remedy the

violations charged and to prevent

proposed respondents from engaging in

similar acts in the future.

Paragraph I of the proposed order

prohibits proposed respondents from

representing that Alen or any other

product: Increases life expectancy;

delays the aging process; eliminates

anemia; increases the immune system’s

defenses; increases memory or

scholastic performance; helps diabetics

naturally produce insulin; reduces the

pain of rheumatism or migraines; lowers

blood pressure; helps heal ulcers,

increases muscle bulk; controls

addictions to excess fat and sweets; or

protects against infections and increases

and enhances the healing process,

unless at the time the representation is

made, respondents possess and rely

upon competent and reliable scientific

evidence that substantiates the

representation.

Paragraph II of the proposed order

prohibits proposed respondents from

making any representation about the

benefits, performance, or efficacy of

Alen, or any food, dietary supplement,

or drug, unless, at the time the

representation is made, proposed

respondents possess and rely upon

competent and reliable scientific

evidence that substantiates the

representation.

Paragraph III of the proposed order

provides that nothing in this order shall

prohibit proposed respondents from

making any representation for any

product permitted by the Food and Drug

Administration. Paragraph IV of the

proposed order provides that nothing in

this order shall prohibit proposed

respondent from making any

representation for any drug permitted by

the Food and Drug Administration.

Paragraph V of the proposed order

requires the proposed respondents to

keep and maintain all advertisements

and promotional materials containing

any representation, and all materials

that were relied upon in disseminating

the representations, covered by the

proposed order. Additionally, Paragraph

VI requires distribution of a copy of the

consent order to current and future

officers and agents. Further, Paragraph

VII provides for Commission

notification upon a change in the

corporate respondent, and Paragraph

VIII requires Commission notification

when the individual respondent

changes his present business or

employment. Paragraph IX requires

proposed respondents to file

compliance reports with the

Commission. Lastly, Paragraph X

provides for the termination of the order

after twenty (20) years under certain

circumstances.

The purpose of this analysis is to

facilitate public comment on the

proposed order, and it is not intended

to constitute an official interpretation of

the agreement and proposed order or to

modify in any way their terms.

Donald S. Clark,

Secretary.

[FR Doc. 97–29279 Filed 11–4–97; 8:45 am]

BILLING CODE 6750–01–M

GENERAL ACCOUNTING OFFICE

Federal Accounting Standards

Advisory Board

AGENCY: General Accounting Office.

ACTION: Cancellation of November

Meeting.

Cancellation

The previously announced meeting

(Federal Register of October 30) on

Friday, November 7, 1997, is hereby

cancelled. Due notice will be given for

the next meeting, to be held on

December 19.

FOR FURTHER INFORMATION CONTACT:

Wendy Comes, Executive Director, 441

G St., N.W., Room 3B18, Washington,

D.C. 20548, or call (202) 512–7350.

Authority: Federal Advisory Committee

Act. Pub. L. No. 92–463, Section 10(a)(2), 86

Stat. 770, 774 (1972) (Current version at 5

U.S.C. app. section 10(a)(2) (1988); 41 CFR

101–6.1015 (1990).

Dated: October 31, 1997.

Wendy M. Comes,

Executive Director.

[FR Doc. 97–29299 Filed 11–4–97; 8:45 am]

BILLING CODE 1610–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Advisory Commission on Consumer

Protection and Quality in the Health

Care Industry’s Ad Hoc Work Group on

Respect and Nondiscrimination; Notice

of Public Meeting

In accordance with Section 10(a)(2) of

the Federal Advisory Committee Act,

Public Law 92–463, notice is hereby

given of the meeting of the Advisory

Commission on Consumer Protection

and Quality in the Health Care